Patent Assignment
Reel/Frame 067863/0149
Assignment of Assignor's Interest
Recorded: 2024-06-27
Pages: 4
Assignor
GLAS, ANNUSKA MARIA
Executed: 2024-04-29
Assignee
AGENDIA N.V.
RADARWEG 60, AMSTERDAM, 1043 NT, NETHERLANDS
Covered Property
(1)
Endocrine Treatment of Hormone Receptor Positive Breast Cancer Typed as Having a Low Risk of Recurrence
Application:
18/289,869 →
Publication:
US 2025/0011873
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jan 15, 2025
From: AGENDIA, INC.; AGENDIA N.V.; AGENDIA INTERNATIONAL B.V.
To: PRINSTED INVESTMENTS LLC, AS AGENT
Reel/Frame 069877/0852 →
Security Interest
Jan 17, 2025
From: AGENDIA, INC.; AGENDIA N.V.; AGENDIA INTERNATIONAL B.V.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 069915/0156 →
Security Interest
Mar 27, 2026
From: AGENDIA, INC.; AGENDIA N.V.; AGENDIA INTERNATIONAL B.V.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 074213/0757 →
Release of Security Interest
Mar 30, 2026
From: PRINSTED INVESTMENTS LLC, AS AGENT
To: AGENDIA, INC.; AGENDIA N.V.; AGENDIA INTERNATIONAL B.V.
Reel/Frame 074220/0505 →